Ethyl bromoacetate → HCID 14975959, compound
Reaction equation
CC(C)([O-])C.[K+].[C:7]([O:11][C:12]([NH:14][C:15]1[C:20]([N+:21]([O-:23])=[O:22])=[CH:19][CH:18]=[CH:17][C:16]=1[F:24])=[O:13])([CH3:10])([CH3:9])[CH3:8].Br[CH2:26][C:27]([O:29][CH2:30][CH3:31])=[O:28]>C1COCC1>[CH2:30]([O:29][C:27](=[O:28])[CH2:26][N:14]([C:12]([O:11][C:7]([CH3:10])([CH3:8])[CH3:9])=[O:13])[C:15]1[C:20]([N+:21]([O-:23])=[O:22])=[CH:19][CH:18]=[CH:17][C:16]=1[F:24])[CH3:31]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
Potassium tert-butoxide (1M in THF, 8,67 ml) is added (dropwise over 5 min) to a solution of N-(tert-butyloxycarbonyl)-2-fluoro-6-nitroaniline (XIX, EXAMPLE 21, 1.85 g) in THF (15 ml) cooled at 0°. After 20 min, ethyl bromoacetate (0.96 ml) is added dropwise over several minutes. The ice bath is removed and the reaction is stirred for 2 h, after which it is partitioned between ethyl acetate, aqueous sodium bicarbonate and saline. The phases are separated, the organic phase is dried over magnesium sulfate and concentrated to give the title compound, NMR (CDCl3) 1.26, 1.35, 1.50, 3.98, 4.10, 4.20, 4.42, 4.45, 7.42 and 7.39 δ.
Workup
- temperaturecooled at 0°
- customThe ice bath is removed
- customafter which it is partitioned between ethyl acetate, aqueous sodium bicarbonate and saline
- customThe phases are separated
- dry with materialthe organic phase is dried over magnesium sulfate
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-8a92a1557a73429693880837b4dcf890
- Source dataset
- uspto-grants-1997_09
- Patent number
- US05668282
Reaction notes
Loading…